Details of the Drug-Related molecule(s) Expression Atlas
General Information of Drug (ID: DMMNH4K)
Drug Name | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
Benzetimidum; 14051-33-3; Benzetimide [INN]; 5633-14-7; CHEMBL10272; Benzetimide (INN); NCGC00160474-01; 2-(1-Benzyl-4-piperidyl)-2-phenylglutarimide; Dexbenzetimide; 119391-55-8; Dextrobenzetimide; Benzezimida; Benzetimidum [INN-Latin]; 2-[1-BENZYL-4-PIPERIDYL]-2-PHENYLGLUTARIMIDE; Benzezimida [INN-Spanish]; [3,4'-Bipiperidine]-2,6-dione, 3-phenyl-1'-(phenylmethyl)-, (S)-; Benzetimide(hydrochloride); 1''-Benzyl-3-phenyl-[3,4'']bipiperidinyl-2,6-dione; AC1L2J7P; DSSTox_RID_81404; DSSTox_CID_26173
|
|||||||||||||||||||
Indication |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecule(s) Related to This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs
|
||||||||||||||||||||||||||
Molecule Expression Atlas in Normal Tissue of Major ADME-related organs | ||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue
The Studied Disease | Discovery agent | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue | ||||||||||||||||||||||||||||||